摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-1-(1-adamantyl)-3-(6-methoxypyridin-3-yl)prop-2-en-1-one | 1012864-80-0

中文名称
——
中文别名
——
英文名称
(E)-1-(1-adamantyl)-3-(6-methoxypyridin-3-yl)prop-2-en-1-one
英文别名
——
(E)-1-(1-adamantyl)-3-(6-methoxypyridin-3-yl)prop-2-en-1-one化学式
CAS
1012864-80-0
化学式
C19H23NO2
mdl
——
分子量
297.397
InChiKey
UXPXYDNAJGOGLZ-DUXPYHPUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    39.2
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    (E)-1-(1-adamantyl)-3-(6-methoxypyridin-3-yl)prop-2-en-1-one三甲基碘化亚砜 在 sodium hydride 作用下, 以 二甲基亚砜 、 mineral oil 为溶剂, 反应 12.25h, 以90%的产率得到adamantan-1-yl-[2-(6-methoxy-pyridin-3-yl)-cyclopropyl]-methanone
    参考文献:
    名称:
    Synergism of virtual screening and medicinal chemistry: Identification and optimization of allosteric antagonists of metabotropic glutamate receptor 1
    摘要:
    We report the identification of novel potent and selective metabotropic glutamate receptor 1 (mGluR1) antagonists by virtual screening and subsequent hit optimization. For ligand-based virtual screening, molecules were represented by a topological pharmacophore descriptor (CATS-2D) and clustered by a self-organizing map (SOM). The most promising compounds were tested in mGluR1 functional and binding assays. We identified a potent chemotype exhibiting selective antagonistic activity at mGluR1 ( functional IC50 = 0.74 +/- 0.29 mu M). Hit optimization yielded lead structure 16 with an affinity of K-i = 0.024 +/- 0.001 mu M and greater than 1000-fold selectivity for mGluR1 versus mGluR5. Homology-based receptor modelling suggests a binding site compatible with previously reported mutation studies. Our study demonstrates the usefulness of ligand-based virtual screening for scaffold-hopping and rapid lead structure identification in early drug discovery projects. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.05.072
点击查看最新优质反应信息